Keyphrases
Breast Cancer Cell Lines
80%
Breast Tumor
100%
Cancer Treatment
20%
Computational Drug Repositioning
100%
Computational Drug Repurposing
20%
Connectivity Map
20%
Drug Perturbation
20%
Drug Repositioning
20%
Drug Resistance
40%
Drug Resistance Profiles
40%
Drug Response
20%
Drug Response Prediction
20%
Drug-resistant Breast Cancer
40%
Drug-resistant Tumor
20%
Early Breast Cancer
20%
Effective Therapy
20%
Estrogen Receptor Antagonist
20%
Estrogenic Response
20%
Fulvestrant
60%
Gene Expression Profile
20%
HER2 Receptor
40%
HER2+
20%
Hormone Receptor-positive
20%
Human Epidermal Growth Factor Receptor 2 (HER2)
20%
I-SPY
40%
Immune Signaling
20%
Improved Patient Outcomes
20%
In Cancer
20%
Matching Strategy
20%
Multidrug-resistant
100%
Neoadjuvant Trials
20%
New Agents
100%
Non-responders
40%
Paclitaxel
40%
Paclitaxel-resistant
40%
Pattern Matching
20%
Potential Drugs
20%
Ranking Method
20%
Receptor Subtypes
100%
Repurposing Approaches
20%
Resistant Breast Cancer
20%
Response Pathways
20%
Triple Negative
20%
Triple-negative Breast Cancer Cells
40%
Tumor
20%
Medicine and Dentistry
Arm
20%
Breast Cancer
60%
Breast Cancer Cell Line
80%
Breast Tumor
100%
Cancer Therapy
20%
Cell Line
20%
Drug Repositioning
100%
Drug Resistance
80%
Drug Response
20%
Estrogen Receptor Antagonist
20%
Fulvestrant
60%
Gene Expression
20%
Hormone Receptor
20%
Immunity
20%
Neoplasm
40%
Paclitaxel
80%
Receptor Subtype
100%
Triple Negative Breast Cancer
40%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Breast Tumor
100%
Drug Repositioning
100%
Drug Resistance
80%
Estrogen Receptor Antagonist
20%
Fulvestrant
60%
Hormone Receptor
20%
Malignant Neoplasm
20%
Neoplasm
40%
Paclitaxel
80%
Receptor Subtype
100%
Triple Negative Breast Cancer
40%
Neuroscience
Cell Line
100%
Drug Resistance
80%
Estrogen Receptor
20%
Fulvestrant
60%
Gene Expression
20%
Hormone Receptor
20%
Paclitaxel
80%
Receptor Antagonist
20%
Receptor Subtype
100%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Drug Resistance
100%
Drug Response
25%
Estrogen Receptor
25%
Fulvestrant
75%
Gene Expression
25%
Hormone Receptor
25%
Immunity
25%
Receptor Antagonist
25%